131 related articles for article (PubMed ID: 24798169)
1. Towards optimising the provision of laboratory services for bone turnover markers.
Vasikaran SD; Chubb SA; Schneider HG
Pathology; 2014 Jun; 46(4):267-73. PubMed ID: 24798169
[TBL] [Abstract][Full Text] [Related]
2. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study.
Ardawi MS; Maimani AA; Bahksh TA; Rouzi AA; Qari MH; Raddadi RM
Bone; 2010 Oct; 47(4):804-14. PubMed ID: 20659600
[TBL] [Abstract][Full Text] [Related]
3. Use of bone turnover markers in clinical practice.
Biver E
Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):468-73. PubMed ID: 23128576
[TBL] [Abstract][Full Text] [Related]
4. Practical Considerations for the Clinical Application of Bone Turnover Markers in Osteoporosis.
Vasikaran SD; Miura M; Pikner R; Bhattoa HP; Cavalier E;
Calcif Tissue Int; 2023 Feb; 112(2):148-157. PubMed ID: 34846540
[TBL] [Abstract][Full Text] [Related]
5. Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis.
Delmas PD; Munoz F; Black DM; Cosman F; Boonen S; Watts NB; Kendler D; Eriksen EF; Mesenbrink PG; Eastell R;
J Bone Miner Res; 2009 Sep; 24(9):1544-51. PubMed ID: 19338427
[TBL] [Abstract][Full Text] [Related]
6. Harmonised Australian Reference Intervals for Serum PINP and CTX in Adults.
Vasikaran SD; Chubb SP; Ebeling PR; Jenkins N; Jones GR; Kotowicz MA; Morris HA; Schneider HG; Seibel MJ; Ward G
Clin Biochem Rev; 2014 Nov; 35(4):237-42. PubMed ID: 25678728
[TBL] [Abstract][Full Text] [Related]
7. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
Vasikaran S; Eastell R; Bruyère O; Foldes AJ; Garnero P; Griesmacher A; McClung M; Morris HA; Silverman S; Trenti T; Wahl DA; Cooper C; Kanis JA;
Osteoporos Int; 2011 Feb; 22(2):391-420. PubMed ID: 21184054
[TBL] [Abstract][Full Text] [Related]
8. Reference intervals of bone turnover markers in healthy premenopausal women: results from a cross-sectional European study.
Eastell R; Garnero P; Audebert C; Cahall DL
Bone; 2012 May; 50(5):1141-7. PubMed ID: 22348982
[TBL] [Abstract][Full Text] [Related]
9. Establishing a reference range for bone turnover markers in young, healthy women.
Glover SJ; Garnero P; Naylor K; Rogers A; Eastell R
Bone; 2008 Apr; 42(4):623-30. PubMed ID: 18289953
[TBL] [Abstract][Full Text] [Related]
10. Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.
Lorentzon M; Branco J; Brandi ML; Bruyère O; Chapurlat R; Cooper C; Cortet B; Diez-Perez A; Ferrari S; Gasparik A; Herrmann M; Jorgensen NR; Kanis J; Kaufman JM; Laslop A; Locquet M; Matijevic R; McCloskey E; Minisola S; Pikner R; Reginster JY; Rizzoli R; Szulc P; Vlaskovska M; Cavalier E
Adv Ther; 2019 Oct; 36(10):2811-2824. PubMed ID: 31440982
[TBL] [Abstract][Full Text] [Related]
11. Measurement and Clinical Utility of βCTX in Serum and Plasma.
Chubb SAP; Vasikaran SD
Adv Clin Chem; 2017; 81():97-134. PubMed ID: 28629592
[TBL] [Abstract][Full Text] [Related]
12. Biochemical assessment of Paget's disease of bone.
Shankar S; Hosking DJ
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P22-7. PubMed ID: 17229003
[TBL] [Abstract][Full Text] [Related]
13. Determinants of bone turnover markers in healthy premenopausal women.
Adami S; Bianchi G; Brandi ML; Giannini S; Ortolani S; DiMunno O; Frediani B; Rossini M;
Calcif Tissue Int; 2008 May; 82(5):341-7. PubMed ID: 18470550
[TBL] [Abstract][Full Text] [Related]
14. Effects of 3 years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis.
Eastell R; Reid DM; Vukicevic S; Ensrud KE; LaCroix AZ; Thompson JR; Thompson DD; Cummings SR
Bone; 2012 May; 50(5):1135-40. PubMed ID: 22348983
[TBL] [Abstract][Full Text] [Related]
15. Bone turnover markers in the management of postmenopausal osteoporosis.
Brown JP; Albert C; Nassar BA; Adachi JD; Cole D; Davison KS; Dooley KC; Don-Wauchope A; Douville P; Hanley DA; Jamal SA; Josse R; Kaiser S; Krahn J; Krause R; Kremer R; Lepage R; Letendre E; Morin S; Ooi DS; Papaioaonnou A; Ste-Marie LG
Clin Biochem; 2009 Jul; 42(10-11):929-42. PubMed ID: 19362543
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of bone turnover biological, preanalytical and technical criteria in the assessment of biochemical markers.
Withold W
Eur J Clin Chem Clin Biochem; 1996 Oct; 34(10):785-99. PubMed ID: 8933101
[TBL] [Abstract][Full Text] [Related]
17. Relationship between bone formation markers bone alkaline phosphatase, osteocalcin and amino-terminal propeptide of type I collagen and bone mineral density in elderly men. Preliminary results.
Lumachi F; Orlando R; Fallo F; Basso SM
In Vivo; 2012; 26(6):1041-4. PubMed ID: 23160690
[TBL] [Abstract][Full Text] [Related]
18. [Biochemical markers of bone turnover : clinical usefulness in osteoporosis].
Garnero P; Delmas PD
Ann Biol Clin (Paris); 1999; 57(2):137-48. PubMed ID: 10210740
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of measurement of bone turnover markers in female patients with systemic lupus erythematosus.
Bogaczewicz J; Karczmarewicz E; Pludowski P; Zabek J; Kowalski J; Lukaszkiewicz J; Wozniacka A
Rev Bras Reumatol; 2015; 55(2):133-9. PubMed ID: 25583000
[TBL] [Abstract][Full Text] [Related]
20. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.
Cortet B; Flipo RM; Pigny P; Duquesnoy B; Racadot A; Boersma A; Delcambre B
Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
